G GRAIL INC
| Market Cap | $2.26B |
| P/E Ratio | — |
| Forward P/E | -6.08 |
| Dividend Yield | — |
| Beta | — |
| 52W Range | $21.39 - $116.06 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Polen Capital Management Polen Capital Management | 0.00% | $1.16M | 13,526 | Reduce 18.87% |
Insider Trading
| Insider Name of the company insider who made the trade 31 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Freidin AaronChief Financial Officer | Sale | 85 | $46.74 | $3.97K | 09 Mar 2026 | 05 Mar 2026 |
| Freidin AaronChief Financial Officer | Sale | 2,407 | $47.93 | $115.37K | 09 Mar 2026 | 05 Mar 2026 |
| Ofman Joshua J.President | Sale | 101 | $46.74 | $4.72K | 09 Mar 2026 | 05 Mar 2026 |
| Ofman Joshua J.President | Sale | 2,836 | $47.93 | $135.93K | 09 Mar 2026 | 05 Mar 2026 |
| RAGUSA ROBERT PChief Executive Officer | Sale | 258 | $46.73 | $12.06K | 09 Mar 2026 | 05 Mar 2026 |
| RAGUSA ROBERT PChief Executive Officer | Sale | 7,203 | $47.93 | $345.24K | 09 Mar 2026 | 05 Mar 2026 |
| Freidin AaronChief Financial Officer | Sale | 655 | $53.01 | $34.72K | 05 Mar 2026 | 05 Mar 2026 |
| Ofman Joshua J.President | Sale | 690 | $53.01 | $36.58K | 05 Mar 2026 | 05 Mar 2026 |
| RAGUSA ROBERT PChief Executive Officer | Sale | 980 | $53.01 | $51.95K | 05 Mar 2026 | 05 Mar 2026 |
| Freidin AaronChief Financial Officer | Sale | 438 | $51.86 | $22.72K | 02 Mar 2026 | 03 Mar 2026 |
| RAGUSA ROBERT PChief Executive Officer | Sale | 1,717 | $51.84 | $89.01K | 02 Mar 2026 | 03 Mar 2026 |
| RAGUSA ROBERT PChief Executive Officer | Sale | 35,787 | $50.09 | $1.79M | 02 Mar 2026 | 03 Mar 2026 |
| Ofman Joshua J.President | Sale | 16,223 | $50.09 | $812.53K | 02 Mar 2026 | 03 Mar 2026 |
| Ofman Joshua J.President | Sale | 779 | $51.75 | $40.31K | 02 Mar 2026 | 03 Mar 2026 |
| Freidin AaronChief Financial Officer | Sale | 9,135 | $50.09 | $457.53K | 02 Mar 2026 | 03 Mar 2026 |
| RAGUSA ROBERT PChief Executive Officer | Sale | 1,604 | $97.28 | $156.04K | 03 Dec 2025 | 05 Dec 2025 |
| RAGUSA ROBERT PChief Executive Officer | Sale | 15,356 | $95.28 | $1.46M | 03 Dec 2025 | 05 Dec 2025 |
| Ofman Joshua J.President | Sale | 13,000 | $100.00 | $1.30M | 03 Dec 2025 | 05 Dec 2025 |
| RAGUSA ROBERT PChief Executive Officer | Sale | 8,233 | $96.22 | $792.15K | 03 Dec 2025 | 05 Dec 2025 |
| RAGUSA ROBERT PChief Executive Officer | Sale | 14,807 | $94.43 | $1.40M | 03 Dec 2025 | 05 Dec 2025 |
| Freidin AaronChief Financial Officer | Sale | 25,000 | $99.15 | $2.48M | 03 Dec 2025 | 05 Dec 2025 |
| ILLUMINA, INC. | Sale | 1,000,000 | $79.85 | $79.85M | 17 Nov 2025 | 18 Nov 2025 |
| Freidin AaronChief Financial Officer | Sale | 1,697 | $79.20 | $134.40K | 17 Nov 2025 | 19 Nov 2025 |
| Aaron FreidinChief Financial Officer | Sale | 1,697 | $79.20 | $134.40K | 17 Nov 2025 | 19 Nov 2025 |
| Ofman Joshua J.President | Sale | 6,114 | $82.01 | $501.41K | 16 Oct 2025 | 16 Oct 2025 |
| Joshua J. OfmanPresident | Sale | 6,114 | $82.01 | $501.41K | 16 Oct 2025 | 16 Oct 2025 |
| Ofman Joshua J.President | Sale | 8,865 | $76.03 | $673.98K | 15 Oct 2025 | 16 Oct 2025 |
| RAGUSA ROBERT PChief Executive Officer | Sale | 7,239 | $68.88 | $498.62K | 15 Oct 2025 | 16 Oct 2025 |
| Robert P RagusaChief Executive Officer | Sale | 7,239 | $68.88 | $498.62K | 15 Oct 2025 | 16 Oct 2025 |
| Joshua J. OfmanPresident | Sale | 8,865 | $76.03 | $673.98K | 15 Oct 2025 | 16 Oct 2025 |
| Ofman Joshua J.President | Sale | 81,385 | $62.50 | $5.09M | 06 Oct 2025 | 08 Oct 2025 |
Frequently Asked Questions
What is GRAL stock price today?
GRAIL INC (GRAL) is currently trading at $54.99. The stock has a 52-week range of $21.39 to $116.06 and a market capitalization of $2.26B.
Is GRAL a good stock to buy in 2026?
GRAIL INC has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of +121.0%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling GRAL stock?
There have been 31 insider transactions for GRAL in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has GRAL stock performed over the past year?
GRAIL INC (GRAL) has returned +121.0% over the past 12 months. The stock traded between $21.39 and $116.06 during this period, and is currently at $54.99.
Which hedge funds own GRAL (GRAIL INC)?
1 tracked hedge funds currently hold GRAL in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is GRAL's market cap and valuation?
GRAIL INC (GRAL) has a market capitalization of $2.26B. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is GRAL's revenue and profitability?
GRAIL INC reported revenue of $147.17M with net income of N/A and a profit margin of N/A. The stock has a beta of N/A.
What sector is GRAL in and who are its biggest institutional holders?
GRAIL INC (GRAL) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.